rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
20	{Pemphigoid, susceptibility to} (2)	C0030805	4	72	2.3274917548832263e-09	1.75746924429e-05	FCGR2A,FCGR2B,FCGR3A,VEGFA
23	Giant cell arteritis	C0039483	4	129	4.448579782323492e-08	2.02108963093e-05	FCGR2A,FCGR2B,FCGR3A,VEGFA
24	Anti-Glomerular Basement Membrane Disease	C0403529	3	49	5.7163037969765185e-08	2.10896309315e-05	FCGR2A,FCGR2B,FCGR3A
25	Pneumonitis	C3714636	3	55	9.173800141759614e-08	2.19683655536e-05	FCGR2A,FCGR3A,VEGFA
28	Meningococcal Infections	C0025303	3	62	1.4945591420012505e-07	2.460456942e-05	FCGR2A,FCGR2B,FCGR3A
31	Severe Dengue	C0019100	3	73	2.900037933128985e-07	2.72407732865e-05	FCGR2A,FCGR2B,VEGFA
32	Mucocutaneous Lymph Node Syndrome	C0026691	4	201	4.0586229987926714e-07	2.81195079086e-05	FCGR2A,FCGR2B,FCGR3A,VEGFA
45	Lupus Nephritis	C0024143	4	226	7.24600443979817e-07	3.95430579965e-05	FCGR2A,FCGR2B,FCGR3A,VEGFA
47	Periodontal Attachment Loss	C0206114	2	28	1.3438497785678294e-06	4.13005272408e-05	FCGR2A,FCGR3A
48	Nephrotic syndrome, type 5, with or without ocular abnormalities	C0027726	4	263	1.528448506982194e-06	4.21792618629e-05	FCGR2A,FCGR2B,FCGR3A,VEGFA
49	Idiopathic thrombocytopenic purpura	C0398650	3	111	1.565891342480974e-06	4.30579964851e-05	FCGR2A,FCGR2B,FCGR3A
63	Periodontal Pocket	C0031094	2	33	2.232552032355173e-06	5.53602811951e-05	FCGR2A,FCGR3A
64	Anterior myocardial infarction	C0340293	2	33	2.232552032355173e-06	5.62390158172e-05	FCGR3A,VEGFA
65	Common variable immunodeficiency 2	C0009447	3	130	2.9418041386231053e-06	5.71177504394e-05	FCGR2A,FCGR2B,FCGR3A
66	Gingival Diseases	C0017563	3	132	3.1261802501125757e-06	5.79964850615e-05	FCGR2A,FCGR3A,VEGFA
67	Alveolar Bone Loss	C0002382	2	37	3.1731536583867737e-06	5.88752196837e-05	FCGR2A,FCGR3A
68	Herpesviridae Infections	C0019372	2	38	3.4433957950552596e-06	5.97539543058e-05	FCGR3A,VEGFA
77	Alveolar proteinosis	C0034050	2	40	4.028798084365626e-06	6.76625659051e-05	FCGR2A,FCGR2B
78	Idiopathic crescentic glomerulonephritis	C0403416	2	41	4.3447218810444e-06	6.85413005272e-05	FCGR3A,VEGFA
79	Diffuse Scleroderma	C1258104	2	41	4.3447218810444e-06	6.94200351494e-05	FCGR2A,FCGR3A
80	Periodontitis	C0031099	4	331	4.706100591334028e-06	7.02987697715e-05	FCGR2A,FCGR2B,FCGR3A,VEGFA
98	Sickle Cell Trait	C0037054	2	47	6.58904392802917e-06	8.61159929701e-05	FCGR2A,FCGR2B
99	Pneumococcal Infections	C0032269	2	50	7.952647560705017e-06	8.69947275923e-05	FCGR2A,FCGR2B
112	Guillain-Barre syndrome, familial	C0018378	2	52	8.958087313049035e-06	9.84182776801e-05	FCGR2A,FCGR3A
113	Nephritis	C0027697	3	178	1.0223773855067009e-05	9.92970123023e-05	FCGR2A,FCGR3A,VEGFA
114	Lymphoma, Follicular	C0024301	4	389	1.0302695964914399e-05	0.000100175746924	FCGR2A,FCGR2B,FCGR3A,VEGFA
115	Chronic Periodontitis	C0266929	3	182	1.116025786329633e-05	0.000101054481547	FCGR2A,FCGR2B,FCGR3A
116	Infection by Cryptococcus neoformans	C0010414	2	57	1.183092813172859e-05	0.000101933216169	FCGR2A,FCGR3A
137	Arthritis, Psoriatic	C0003872	3	204	1.748640932031087e-05	0.000120386643234	FCGR2A,FCGR3A,VEGFA
138	{Spondyloarthropathy, susceptibility to, 1}, 106300 (3)	C0949690	2	68	2.0152937953432648e-05	0.000121265377856	FCGR2A,FCGR2B
149	Acute Lung Injury	C0242488	2	71	2.294923706969154e-05	0.000130931458699	FCGR2B,VEGFA
150	Granulomatosis with Polyangiitis	C3495801	2	74	2.5989699860340387e-05	0.000131810193322	FCGR2A,FCGR3A
162	Ovarian Diseases	C0029928	3	236	3.0948302548683415e-05	0.000142355008787	FCGR2A,FCGR2B,VEGFA
178	Lichen Planus, Oral	C0206139	2	83	3.667278065999646e-05	0.000156414762742	FCGR2A,FCGR2B
188	Candidiasis, familial, 9	C0006840	2	85	3.938320056995348e-05	0.000165202108963	FCGR2A,FCGR3A
189	Recurrent bacterial infection	C0004623	3	255	4.186553129881254e-05	0.000166080843585	FCGR2A,FCGR2B,VEGFA
190	Neutropenia	C0027947	3	255	4.186553129881254e-05	0.000166959578207	FCGR2A,FCGR2B,FCGR3A
191	Parasitemia	C0242723	2	89	4.5191927407595145e-05	0.00016783831283	FCGR2A,FCGR2B
202	Periodontitis, Juvenile	C0031106	2	90	4.6727052361417165e-05	0.000177504393673	FCGR2A,FCGR3A
203	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	C0152025	2	90	4.6727052361417165e-05	0.000178383128295	FCGR3A,VEGFA
204	Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy	C0852949	2	90	4.6727052361417165e-05	0.000179261862917	FCGR2B,VEGFA
205	Urinary tract infection	C0042029	2	92	4.9899016658416784e-05	0.00018014059754	FCGR3A,VEGFA
206	Merkel cell carcinoma	C0007129	2	94	5.320912304429548e-05	0.000181019332162	FCGR3A,VEGFA
216	Biliary Atresia	C0005411	2	96	5.6660179148182443e-05	0.000189806678383	FCGR3A,VEGFA
217	Interstitial fibrosis	C3887486	2	97	5.8439368048501805e-05	0.000190685413005	FCGR3A,VEGFA
218	Inflammatory disorder	C1290884	3	279	5.9400444357482485e-05	0.000191564147627	FCGR2B,FCGR3A,VEGFA
243	Rheumatic disease of heart valve	C0035435	2	108	8.047723635951076e-05	0.000213532513181	FCGR3A,VEGFA
244	Helicobacter Infections	C0079487	2	110	8.4990430552212e-05	0.000214411247803	FCGR2A,VEGFA
245	Lupus Vulgaris	C0024131	3	307	8.604083557017805e-05	0.000215289982425	FCGR2A,FCGR2B,FCGR3A
252	Graft-versus-host disease, susceptibility to	C0018133	3	317	9.738350589394429e-05	0.00022144112478	FCGR2A,FCGR3A,VEGFA
253	Meningitis	C0497299	2	116	9.951526908569264e-05	0.000222319859402	FCGR2A,FCGR3A
254	Discoid lupus erythematosus	C0024138	3	319	9.977661744375865e-05	0.000223198594025	FCGR2A,FCGR2B,FCGR3A
259	Acute Coronary Syndrome	C0948089	3	320	0.00010098914447531637	0.000227592267135	FCGR2A,FCGR3A,VEGFA
269	Lymphopenia	C0024312	2	122	0.00011557335938483515	0.000236379613357	FCGR3A,VEGFA
270	Hepatitis, Autoimmune	C0241910	2	123	0.00011840369171545184	0.000237258347979	FCGR2A,FCGR2B
271	IgA nephropathy, susceptibility to, 3	C0017661	4	650	0.00011933954498410948	0.000238137082601	FCGR2A,FCGR2B,FCGR3A,VEGFA
272	B-cell lymphoma	C0079731	4	652	0.00012107366880320658	0.000239015817223	FCGR2A,FCGR2B,FCGR3A,VEGFA
295	Pleural effusion	C0032227	2	137	0.00016288459973634595	0.000259226713533	FCGR3A,VEGFA
296	Rhinitis, Allergic, Seasonal	C0035455	2	138	0.00016642128618171714	0.000260105448155	FCGR2A,VEGFA
297	Leg Ulcer	C0023223	1	25	0.0001747422748364924	0.000260984182777	VEGFA
298	Isovaleryl-CoA dehydrogenase deficiency	C0268575	1	25	0.0001747422748364924	0.000261862917399	VEGFA
299	High altitude pulmonary edema	C0340100	1	25	0.0001747422748364924	0.000262741652021	VEGFA
300	Kashin-Beck Disease	C2745963	1	25	0.0001747422748364924	0.000263620386643	VEGFA
301	Fibromyxosarcoma	C3714524	1	25	0.0001747422748364924	0.000264499121265	VEGFA
302	Graves Disease	C0018213	3	374	0.00018391207708856605	0.000265377855888	FCGR2A,FCGR3A,VEGFA
303	Papillary adenocarcinoma	C0001420	1	26	0.00018921514955438923	0.00026625659051	VEGFA
304	Placental Insufficiency	C0032051	1	26	0.00018921514955438923	0.000267135325132	VEGFA
305	Hereditary hemorrhagic telangiectasia type 2	C0039445	1	26	0.00018921514955438923	0.000268014059754	VEGFA
306	recurrent childhood acute lymphoblastic leukemia	C0278519	1	26	0.00018921514955438923	0.000268892794376	VEGFA
307	Malaria, Falciparum	C0024535	2	147	0.00020052190004760106	0.000269771528998	FCGR2A,FCGR2B
308	Esophageal varix	C0014867	1	27	0.000204256363170785	0.00027065026362	VEGFA
309	Tuberculosis, Meningeal	C0041318	1	27	0.000204256363170785	0.000271528998243	VEGFA
310	Steroid-sensitive nephrotic syndrome	C0403396	1	27	0.000204256363170785	0.000272407732865	VEGFA
311	Invasive Skin Melanoma	C1708565	1	27	0.000204256363170785	0.000273286467487	VEGFA
312	Essential thrombocythemia	C0040028	2	150	0.00021282075145523383	0.000274165202109	FCGR2A,VEGFA
313	{Aneurysm, familial abdominal 3} (2)	C0002940	2	151	0.0002170265607219779	0.000275043936731	FCGR2A,VEGFA
314	Urothelial Carcinoma	C0007138	3	391	0.00021799161575730697	0.000275922671353	FCGR2A,FCGR2B,VEGFA
315	Otitis Media with Effusion	C0029883	1	28	0.00021986498748183259	0.000276801405975	VEGFA
316	Thrombosis of retinal vein	C0035328	1	28	0.00021986498748183259	0.000277680140598	VEGFA
317	Squamous cell carcinoma of the hypopharynx	C0280321	1	28	0.00021986498748183259	0.00027855887522	VEGFA
318	Abnormal breathing	C1260922	1	28	0.00021986498748183259	0.000279437609842	VEGFA
319	Astrocytoma, low grade	C1314694	1	28	0.00021986498748183259	0.000280316344464	VEGFA
320	Congenital vascular anomaly	C1961121	1	28	0.00021986498748183259	0.000281195079086	VEGFA
321	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	3	393	0.00022228095020271343	0.000282073813708	FCGR2A,FCGR2B,FCGR3A
322	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	C0002878	2	153	0.000225599312892788	0.00028295254833	FCGR2A,FCGR2B
323	Femur Head Necrosis	C0015814	1	29	0.00023604032740354164	0.000283831282953	VEGFA
324	Squamous Cell Neoplasms	C0206720	1	29	0.00023604032740354164	0.000284710017575	VEGFA
325	Proliferative retinopathy	C0339467	1	29	0.00023604032740354164	0.000285588752197	VEGFA
326	Coronary heart disease 7	C0010054	4	754	0.0002386728116644532	0.000286467486819	FCGR2A,FCGR2B,FCGR3A,VEGFA
327	Kidney Diseases	C0022658	4	755	0.00024014578269959674	0.000287346221441	FCGR2A,FCGR2B,FCGR3A,VEGFA
328	Thrombosis	C0040053	2	157	0.00024339774243375967	0.000288224956063	FCGR2A,VEGFA
329	Malignant neoplasm of brain and nervous system	C0153633	2	157	0.00024339774243375967	0.000289103690685	FCGR2A,FCGR3A
330	Respiratory tract infection	C0035243	3	404	0.00024697171993559586	0.000289982425308	FCGR2A,FCGR2B,FCGR3A
331	Bacterial endocarditis	C0014121	1	30	0.0002527814830444175	0.00029086115993	FCGR2A
332	T-Cell Prolymphocytic Leukemia	C0023494	1	30	0.0002527814830444175	0.000291739894552	VEGFA
333	Myxoma	C0027149	1	30	0.0002527814830444175	0.000292618629174	VEGFA
334	AIDS-Associated Nephropathy	C0078911	1	30	0.0002527814830444175	0.000293497363796	VEGFA
335	Aortic valve calcification	C0428791	1	30	0.0002527814830444175	0.000294376098418	VEGFA
336	Peritoneal Fibrosis	C0521607	1	30	0.0002527814830444175	0.00029525483304	VEGFA
337	Chromophobe Renal Cell Carcinoma	C1266042	1	30	0.0002527814830444175	0.000296133567663	VEGFA
338	Myeloproliferative disorder, chronic, with eosinophilia	C1851585	1	30	0.0002527814830444175	0.000297012302285	VEGFA
339	Behcet Syndrome	C0004943	3	407	0.0002540357528602044	0.000297891036907	FCGR2A,FCGR3A,VEGFA
340	Progressive Neoplastic Disease	C0677932	2	161	0.00026208271204697375	0.000298769771529	FCGR3A,VEGFA
341	Progressive cGVHD	C3539781	2	161	0.00026208271204697375	0.000299648506151	FCGR3A,VEGFA
342	Gallbladder Diseases	C0016977	1	31	0.0002700877297294735	0.000300527240773	VEGFA
343	Granuloma	C0018188	1	31	0.0002700877297294735	0.000301405975395	VEGFA
344	Intermittent claudication	C0021775	1	31	0.0002700877297294735	0.000302284710018	VEGFA
345	Monocytosis	C0085702	1	31	0.0002700877297294735	0.00030316344464	FCGR2B
346	Neoplasm of the thymus	C3714644	1	31	0.0002700877297294735	0.000304042179262	FCGR2A
347	Acquired Immunodeficiency Syndrome	C0001175	2	163	0.0002717635668718632	0.000304920913884	FCGR3A,VEGFA
348	Albuminuria	C0001925	2	163	0.0002717635668718632	0.000305799648506	FCGR2A,VEGFA
349	Angiokeratoma	C0002985	1	32	0.00028795820367044644	0.000306678383128	VEGFA
350	Puerperal Disorders	C0034040	1	32	0.00028795820367044644	0.00030755711775	FCGR2A
351	Truncus arteriosus	C0041206	1	32	0.00028795820367044644	0.000308435852373	VEGFA
352	Vascular malformation, primary intraosseous	C0158570	1	32	0.00028795820367044644	0.000309314586995	VEGFA
353	Niemann-Pick disease, type C	C0220756	1	32	0.00028795820367044644	0.000310193321617	VEGFA
354	Arteriovenous hemangioma	C0334533	1	32	0.00028795820367044644	0.000311072056239	VEGFA
355	Recurrent sinusitis	C0581354	1	32	0.00028795820367044644	0.000311950790861	FCGR3A
356	Stenosis	C0678234	1	32	0.00028795820367044644	0.000312829525483	VEGFA
357	TNF receptor-associated periodic fever syndrome (TRAPS)	C3889979	1	32	0.00028795820367044644	0.000313708260105	FCGR3A
358	Recessive dystrophic epidermolysis bullosa	C0079474	1	33	0.000306392093217589	0.000314586994728	VEGFA
359	Stage IV Ovarian Carcinoma	C0278688	1	33	0.000306392093217589	0.00031546572935	VEGFA
360	Generalized osteoarthritis	C0409952	1	33	0.000306392093217589	0.000316344463972	VEGFA
361	Prostatitis	C0497496	1	33	0.000306392093217589	0.000317223198594	VEGFA
362	Tumor necrosis	C0333516	2	170	0.00030746357012234604	0.000318101933216	FCGR3A,VEGFA
